MicroRNAs and their target gene networks in breast cancer

Elizabeth O'Day1, Ashish Lal

  • 1Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. odayel@gmail.com

Insights

Altered microRNA (miRNA) expression is linked to breast cancer development and spread. Changes in tumor suppressor and oncogenic miRNAs disrupt key cellular pathways, contributing to this complex disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small RNA molecules regulating gene expression post-transcriptionally.
  • Aberrant miRNA expression is increasingly recognized in human cancers, particularly breast cancer.
  • Specific miRNA signatures are associated with tumorigenesis and metastasis in breast cancer.

Purpose of the Study:

  • To investigate the association between altered miRNA expression profiles and breast cancer.
  • To identify specific tumor suppressor and oncogenic miRNAs involved in breast cancer.
  • To understand how miRNA perturbations disrupt key pathways in breast cancer.

Main Methods:

  • Analysis of miRNA expression profiles in breast cancer samples.
  • Identification of differentially expressed tumor suppressor and oncogenic miRNAs.
  • Investigation of miRNA targets and their role in disease pathways.

Main Results:

  • Loss of tumor suppressor miRNAs (e.g., miR-206, let-7) and overexpression of oncogenic miRNAs (e.g., miR-21, miR-155) observed in breast cancer.
  • Key miRNA targets contributing to the disease phenotype have been identified.
  • Perturbations in miRNA expression profiles disrupt critical pathways involved in breast cancer progression.

Conclusions:

  • Altered miRNA signatures are significantly associated with breast cancer tumorigenesis and metastasis.
  • Dysregulation of specific miRNAs contributes to the development and progression of breast cancer.
  • Understanding miRNA networks is crucial for deciphering breast cancer pathogenesis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...